A Trojan Horse for Parkinson’s Disease

See allHide authors and affiliations

Sci. Signal.  06 Apr 2010:
Vol. 3, Issue 116, pp. pe13
DOI: 10.1126/scisignal.3116pe13

You are currently viewing the abstract.

View Full Text


Pathogenic mutations in leucine-rich repeat kinase 2 (LRRK2) are common genetic causes of late-onset Parkinson’s disease (PD). Initial studies indicated that the intrinsic kinase activity of LRRK2 is associated with LRRK2-mediated PD pathogenesis. However, LRRK2 kinase activity may be dispensable for neuron survival and may not be required for its protective activity against neurotoxicity. Thus, the intrinsic kinase activity of LRRK2 appears to be a Trojan horse for PD, and inhibition of its kinase activity could potentially be therapeutically beneficial.

View Full Text